Atomo Diagnostics Ltd

Healthcare • Medical Devices • Quote as of 11/04/2026 16:10

Company Profile

IndustryMedical Devices

SectorHealthcare

Market Capitalization12.63 mln

Float811 mln

Earnings Date02/24/2027

Piotroski F-Score

5 / 9

Neutral

Beneish M-Score

-1.64

Likely manipulated

Relative Strength

8 / 100

Severely lagging

Debt / Equity

0.05

Debt-free

Pre-Tax Margin

-90%

Severely loss-making

ROE

-49.42

Deeply negative

Business Description

Atomo Diagnostics is an Australian medical device company founded in 2010 and based in Leichhardt. It sells a range of rapid blood testing products globally under its AtomoRapid brand, including several named devices and an HIV self-test kit. The company also provides digital health tools to support its testing solutions.

Key Fundamentals

EPS-0.00

ROE-49.42

RPS0.01

ROIC-77.53

ROA-35.63

Interest Cover-386

EBITDA, mln-3.33

EV / EBITDA-3.36

EV / EBIT-2.35

Revenue, mln5.33

EV / Revenue2.10

Quote Details

Last 0.014

Change 0 (0%)

Open 0.016

Volume 3,294,270

Turnover 46,120

Average Volume 1,653,057

Financial Ratios

Pre-Tax Profit Margin-90

Leverage Ratio1.40

Current Ratio3.04

Price / Book1.78

Price / Tangible Book1.60

Debt / Equity0.05

Price / Sales2.29

Financial Strength

Altman Z-Score-6.2

Piotroski F-Score 5 / 9

Beneish M-Score-1.64

Price Performance & Relative Strength

Period	Price Performance	Relative Strength
1 Week	-12.5%	13 / 100
1 Month	-22.22%	19 / 100
2 Months	-12.5%	35 / 100
6 Months	-48.15%	15 / 100
1 Year	-50%	19 / 100